BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9761771)

  • 21. Interaction of macrophage-stimulating protein with its receptor. Residues critical for beta chain binding and evidence for independent alpha chain binding.
    Danilkovitch A; Miller M; Leonard EJ
    J Biol Chem; 1999 Oct; 274(42):29937-43. PubMed ID: 10514476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage-specific elevated expression of the genes for hepatocyte growth factor, keratinocyte growth factor, and their receptors during the morphogenesis and differentiation of rat stomach mucosa.
    Matsubara Y; Ichinose M; Tatematsu M; Ichinose M; Oka M; Yahagi N; Kurokawa K; Kageyama T; Miki K; Fukamachi H
    Biochem Biophys Res Commun; 1996 May; 222(3):669-77. PubMed ID: 8651903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
    Iwama A; Yamaguchi N; Suda T
    EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scatter factor and its relationship to hepatocyte growth factor and met.
    Rosen EM; Knesel J; Goldberg ID
    Cell Growth Differ; 1991 Nov; 2(11):603-7. PubMed ID: 1839956
    [No Abstract]   [Full Text] [Related]  

  • 25. A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist.
    Tolbert WD; Daugherty J; Gao C; Xie Q; Miranti C; Gherardi E; Vande Woude G; Xu HE
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14592-7. PubMed ID: 17804794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoforms of human HGF and their biological activities.
    Chan A; Rubin J; Bottaro D; Hirschfield D; Chedid M; Aaronson SA
    EXS; 1993; 65():67-79. PubMed ID: 8380745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
    Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A
    Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.
    Rodrigues GA; Park M
    Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development.
    Théry C; Sharpe MJ; Batley SJ; Stern CD; Gherardi E
    Dev Genet; 1995; 17(1):90-101. PubMed ID: 7554499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoforms of the met receptor tyrosine kinase.
    Rodrigues GA; Park M
    EXS; 1993; 65():167-79. PubMed ID: 8380736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay between scatter factor receptors and B plexins controls invasive growth.
    Conrotto P; Corso S; Gamberini S; Comoglio PM; Giordano S
    Oncogene; 2004 Jul; 23(30):5131-7. PubMed ID: 15184888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation.
    Gregorini M; Bosio F; Rocca C; Corradetti V; Valsania T; Pattonieri EF; Esposito P; Bedino G; Collesi C; Libetta C; Frassoni F; Dal Canton A; Rampino T
    BMC Immunol; 2014 Oct; 15():44. PubMed ID: 25277788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.
    Nakamura T
    Princess Takamatsu Symp; 1994; 24():195-213. PubMed ID: 8983076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The structural biology of growth factor receptor activation.
    Harmer NJ; Chirgadze D; Hyun Kim K; Pellegrini L; Blundell TL
    Biophys Chem; 2003; 100(1-3):545-53. PubMed ID: 12646390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene.
    Vigna E; Naldini L; Tamagnone L; Longati P; Bardelli A; Maina F; Ponzetto C; Comoglio PM
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):597-604. PubMed ID: 7981617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines.
    Chen Q; Seol DW; Carr B; Zarnegar R
    Hepatology; 1997 Jul; 26(1):59-66. PubMed ID: 9214452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors.
    Wilson SE; Weng J; Chwang EL; Gollahon L; Leitch AM; Shay JW
    Cell Mol Biol Res; 1994; 40(4):337-50. PubMed ID: 7866434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mode of receptor binding and activation by plasminogen-related growth factors.
    Miller M; Leonard EJ
    FEBS Lett; 1998 Jun; 429(1):1-3. PubMed ID: 9657372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts.
    Rygaard K; Nakamura T; Spang-Thomsen M
    Br J Cancer; 1993 Jan; 67(1):37-46. PubMed ID: 7678980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity.
    Michieli P; Cavassa S; Basilico C; De Luca A; Mazzone M; Asti C; Chiusaroli R; Guglielmi M; Bossù P; Colotta F; Caselli G; Comoglio PM
    Nat Biotechnol; 2002 May; 20(5):488-95. PubMed ID: 11981563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.